MESALAMINE
MESALAMINE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: MESALAMINE; Generic name: MESALAMINE; Drug class: Aminosalicylate [EPC].
| Brand name | MESALAMINE |
|---|---|
| Generic name | MESALAMINE |
| Drug class | Aminosalicylate [EPC] |
| Manufacturer | Bryant Ranch Prepack |
| Used for | 1 INDICATIONS AND USAGE Mesalamine delayed-release tablets are indicated for the: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg. Mesalamine delayed-release tablets are an aminosalicylate indicated for the: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. ( 1 ) treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg. (1) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Administration Instructions Evaluate renal function prior to initiation of mesalamine delayed-release tablets and periodically while on therapy. ( 2 , 5.1 ) Swallow mesalamine delayed-release tablets whole; do not split or crush. ( 2 ) Administer mesalamine delayed-release tablets with food. ( 2 ) Drink an adequate amount of fluids. ( 2 , 5.8 ) Recommended Dosage in Adults For induction of remission : 2.4 g to 4.8 g (two to four 1.2-g tablets) once daily. ( 2 ) For ma |
| Active ingredient(s) | MESALAMINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=063ca661-1b5c-4941-a5b9-5dd0fa46b3d0 |